William Hyun

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

Scribe Biosciences, Inc. operates as a biotechnology company. The company is based in San Francisco, CA. The company was founded by Srinivasan Maithreyan, Zev Gartner, Adam Abate, Russell Cole. The CEO is Russell Cole.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Scribe Biosciences, Inc. operates as a biotechnology company. The company is based in San Francisco, CA. The company was founded by Srinivasan Maithreyan, Zev Gartner, Adam Abate, Russell Cole. The CEO is Russell Cole.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.